Jason Cole - Publications

Affiliations: 
2008-2012 University of California, San Diego, La Jolla, CA 

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Henningham A, Davies MR, Uchiyama S, van Sorge NM, Lund S, Chen KT, Walker MJ, Cole JN, Nizet V. Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A Streptococcus. Mbio. 9. PMID 29382733 DOI: 10.1128/mBio.02294-17  0.76
2017 Döhrmann S, LaRock CN, Anderson EL, Cole JN, Ryali B, Stewart C, Nonejuie P, Pogliano J, Corriden R, Ghosh P, Nizet V. Group A Streptococcal M1 Protein Provides Resistance against the Antimicrobial Activity of Histones. Scientific Reports. 7: 43039. PMID 28220899 DOI: 10.1038/srep43039  0.76
2016 Stewart CM, Buffalo CZ, Valderrama JA, Henningham A, Cole JN, Nizet V, Ghosh P. Coiled-coil destabilizing residues in the group A Streptococcus M1 protein are required for functional interaction. Proceedings of the National Academy of Sciences of the United States of America. PMID 27512043 DOI: 10.1073/pnas.1606160113  0.76
2016 Döhrmann S, Cole JN, Nizet V. Conquering Neutrophils. Plos Pathogens. 12: e1005682. PMID 27467389 DOI: 10.1371/journal.ppat.1005682  0.76
2016 Rivera-Hernandez T, Pandey M, Henningham A, Cole J, Choudhury B, Cork AJ, Gillen CM, Ghaffar KA, West NP, Silvestri G, Good MF, Moyle PM, Toth I, Nizet V, Batzloff MR, et al. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models. Mbio. 7. PMID 27302756 DOI: 10.1128/mBio.00618-16  0.76
2016 Cole JN, Nizet V. Bacterial Evasion of Host Antimicrobial Peptide Defenses. Microbiology Spectrum. 4. PMID 26999396 DOI: 10.1128/microbiolspec.VMBF-0006-2015  0.76
2015 Barnett TC, Cole JN, Rivera-Hernandez T, Henningham A, Paton JC, Nizet V, Walker MJ. Streptococcal toxins: role in pathogenesis and disease. Cellular Microbiology. PMID 26433203 DOI: 10.1111/cmi.12531  0.76
2015 Secundino I, Lizcano A, Roupé KM, Wang X, Cole JN, Olson J, Ali SR, Dahesh S, Amayreh LK, Henningham A, Varki A, Nizet V. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation. Journal of Molecular Medicine (Berlin, Germany). PMID 26411873 DOI: 10.1007/s00109-015-1341-8  0.76
2015 Xu D, Olson J, Cole JN, van Wijk XM, Brinkmann V, Zychlinsky A, Nizet V, Esko JD, Chang YC. Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity. Infection and Immunity. 83: 3648-56. PMID 26150541 DOI: 10.1128/IAI.00545-15  0.76
2015 Henningham A, Döhrmann S, Nizet V, Cole JN. Mechanisms of group A Streptococcus resistance to reactive oxygen species. Fems Microbiology Reviews. 39: 488-508. PMID 25670736 DOI: 10.1093/femsre/fuu009  0.76
2014 Henningham A, Yamaguchi M, Aziz RK, Kuipers K, Buffalo CZ, Dahesh S, Choudhury B, Van Vleet J, Yamaguchi Y, Seymour LM, Ben Zakour NL, He L, Smith HV, Grimwood K, Beatson SA, ... ... Cole JN, et al. Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus. The Journal of Biological Chemistry. 289: 32303-15. PMID 25266727 DOI: 10.1074/jbc.M114.602847  0.44
2014 van Sorge NM, Cole JN, Kuipers K, Henningham A, Aziz RK, Kasirer-Friede A, Lin L, Berends ET, Davies MR, Dougan G, Zhang F, Dahesh S, Shaw L, Gin J, Cunningham M, et al. The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. Cell Host & Microbe. 15: 729-40. PMID 24922575 DOI: 10.1016/j.chom.2014.05.009  0.76
2014 ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. Omics : a Journal of Integrative Biology. 18: 402-14. PMID 24785449 DOI: 10.1089/omi.2014.0018  0.68
2014 Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML, Nizet V. Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clinical Microbiology Reviews. 27: 264-301. PMID 24696436 DOI: 10.1128/CMR.00101-13  0.76
2014 Anderson EL, Cole JN, Olson J, Ryba B, Ghosh P, Nizet V. The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus. The Journal of Biological Chemistry. 289: 3539-46. PMID 24356958 DOI: 10.1074/jbc.M113.529537  0.76
2013 Tsatsaronis JA, Hollands A, Cole JN, Maamary PG, Gillen CM, Ben Zakour NL, Kotb M, Nizet V, Beatson SA, Walker MJ, Sanderson-Smith ML. Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2633-43. PMID 23531597 DOI: 10.1096/fj.12-226662  0.76
2012 Dahesh S, Nizet V, Cole JN. Study of streptococcal hemoprotein receptor (Shr) in iron acquisition and virulence of M1T1 group A streptococcus. Virulence. 3: 566-75. PMID 23076332 DOI: 10.4161/viru.21933  0.76
2012 Cole JN, Aziz RK, Kuipers K, Timmer AM, Nizet V, van Sorge NM. A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus. Journal of Bacteriology. 194: 6154-61. PMID 22961854 DOI: 10.1128/JB.01317-12  0.76
2012 Maamary PG, Ben Zakour NL, Cole JN, Hollands A, Aziz RK, Barnett TC, Cork AJ, Henningham A, Sanderson-Smith M, McArthur JD, Venturini C, Gillen CM, Kirk JK, Johnson DR, Taylor WL, et al. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4675-84. PMID 22878963 DOI: 10.1096/fj.12-212142  0.76
2012 Henningham A, Chiarot E, Gillen CM, Cole JN, Rohde M, Fulde M, Ramachandran V, Cork AJ, Hartas J, Magor G, Djordjevic SP, Cordwell SJ, Kobe B, Sriprakash KS, Nizet V, et al. Conserved anchorless surface proteins as group A streptococcal vaccine candidates. Journal of Molecular Medicine (Berlin, Germany). 90: 1197-207. PMID 22527883 DOI: 10.1007/s00109-012-0897-9  0.76
2011 Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nature Reviews. Microbiology. 9: 724-36. PMID 21921933 DOI: 10.1038/nrmicro2648  0.76
2011 Amelung S, Nerlich A, Rohde M, Spellerberg B, Cole JN, Nizet V, Chhatwal GS, Talay SR. The FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells. Cellular Microbiology. 13: 1200-11. PMID 21615663 DOI: 10.1111/j.1462-5822.2011.01610.x  0.76
2011 Macheboeuf P, Buffalo C, Fu CY, Zinkernagel AS, Cole JN, Johnson JE, Nizet V, Ghosh P. Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature. 472: 64-8. PMID 21475196 DOI: 10.1038/nature09967  0.76
2010 Cole JN, Pence MA, von Köckritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. Mbio. 1. PMID 20827373 DOI: 10.1128/mBio.00191-10  0.76
2010 Pence MA, Rooijakkers SH, Cogen AL, Cole JN, Hollands A, Gallo RL, Nizet V. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. Journal of Innate Immunity. 2: 587-95. PMID 20814187 DOI: 10.1159/000317672  0.76
2010 Maamary PG, Sanderson-Smith ML, Aziz RK, Hollands A, Cole JN, McKay FC, McArthur JD, Kirk JK, Cork AJ, Keefe RJ, Kansal RG, Sun H, Taylor WL, Chhatwal GS, Ginsburg D, et al. Parameters governing invasive disease propensity of non-M1 serotype group A streptococci. Journal of Innate Immunity. 2: 596-606. PMID 20814186 DOI: 10.1159/000317640  0.76
2008 Cole JN, Henningham A, Gillen CM, Ramachandran V, Walker MJ. Human pathogenic streptococcal proteomics and vaccine development. Proteomics. Clinical Applications. 2: 387-410. PMID 21136841 DOI: 10.1002/prca.200780048  0.76
2008 McArthur JD, McKay FC, Ramachandran V, Shyam P, Cork AJ, Sanderson-Smith ML, Cole JN, Ringdahl U, Sjöbring U, Ranson M, Walker MJ. Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 3146-53. PMID 18511548 DOI: 10.1096/fj.08-109348  0.4
2008 Cole JN, Djordjevic SP, Walker MJ. Isolation and solubilization of gram-positive bacterial cell wall-associated proteins Methods in Molecular Biology (Clifton, N.J.). 425: 295-311. PMID 18369905  0.76
2007 Cole JN, Aquilina JA, Hains PG, Henningham A, Sriprakash KS, Caparon MG, Nizet V, Kotb M, Cordwell SJ, Djordjevic SP, Walker MJ. Role of group A Streptococcus HtrA in the maturation of SpeB protease. Proteomics. 7: 4488-98. PMID 18072207 DOI: 10.1002/pmic.200700626  0.76
2007 Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, McArthur JD, Dinkla K, Aziz RK, Kansal RG, Simpson AJ, Buchanan JT, Chhatwal GS, Kotb M, Nizet V. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nature Medicine. 13: 981-5. PMID 17632528 DOI: 10.1038/nm1612  0.76
2006 Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, Ranson M, Rohde M, Itzek A, Sun H, Ginsburg D, Kotb M, Nizet V, Chhatwal GS, Walker MJ. Trigger for group A streptococcal M1T1 invasive disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1745-7. PMID 16790522 DOI: 10.1096/fj.06-5804fje  0.76
2005 Cole JN, Ramirez RD, Currie BJ, Cordwell SJ, Djordjevic SP, Walker MJ. Surface analyses and immune reactivities of major cell wall-associated proteins of group a streptococcus. Infection and Immunity. 73: 3137-46. PMID 15845522 DOI: 10.1128/IAI.73.5.3137-3146.2005  0.4
2003 McArthur JD, West NP, Cole JN, Jungnitz H, Guzmán CA, Chin J, Lehrbach PR, Djordjevic SP, Walker MJ. An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. Fems Microbiology Letters. 221: 7-16. PMID 12694904  0.4
Show low-probability matches.